UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

Annals of oncology, 2020-11, Vol.31 (11), p.1518-1525

2020

Volltextzugriff (PDF)

ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)

Annals of oncology, 2020-06, Vol.31 (6), p.674-696

2020

Volltextzugriff (PDF)

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

JNCI : Journal of the National Cancer Institute, 2003-12, Vol.95 (23), p.1758-1764

2003

Volltextzugriff (PDF)

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

Annals of oncology, 2007-12, Vol.18 (12), p.1927-1934

2007

Volltextzugriff (PDF)

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment

JNCI : Journal of the National Cancer Institute, 2005-01, Vol.97 (1), p.30-39

2005

Volltextzugriff (PDF)

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of oncology, 2023-10, Vol.34 (10), p.899-906

2023

Volltextzugriff (PDF)

Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer

Annals of oncology, 2008-10, Vol.19 (10), p.1669-1680

2008

Volltextzugriff (PDF)

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1063-1072

2012

Volltextzugriff (PDF)

When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2334-2356

2001

Volltextzugriff (PDF)

Abstract ED01-01: Optimizing endocrine therapy in premenopausal women

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.ED01-01-ED01-01

Stearns, V.

2024

Volltextzugriff (PDF)

Abstract CS1-2: Searching for the optimal duration of adjuvant endocrine therapy in breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.CS1-2-CS1-2

Stearns, V

2018

Volltextzugriff (PDF)

Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

Clinical pharmacology and therapeutics, 2011-11, Vol.90 (5), p.693-700

2011

Volltextzugriff (PDF)

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer

The pharmacogenomics journal, 2017-12, Vol.17 (6), p.521-527

2017

Volltextzugriff (PDF)

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

The pharmacogenomics journal, 2009-08, Vol.9 (4), p.258-264

2009

Volltextzugriff (PDF)

Predictors of recovery of ovarian function during aromatase inhibitor therapy

Annals of oncology, 2013-08, Vol.24 (8), p.2011-2016

2013

Volltextzugriff (PDF)

Increased African-American Enrollment in Breast Cancer Clinical Trials: A Single-Institution Experience

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S597-S597

2014

Volltextzugriff (PDF)

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors

Annals of oncology, 2000-01, Vol.11 (1), p.17-22

2000

Volltextzugriff (PDF)

Two Phase 1/2 Trials of Partial Breast Irradiation (PBI) With Concurrent Chemotherapy Regimens: Late Toxicity, Cosmetic Outcome, and Disease Recurrence

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S275-S276

2014

Volltextzugriff (PDF)

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects

British journal of cancer, 2013-10, Vol.109 (9), p.2331-2339

2013

Volltextzugriff (PDF)

New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17

Breast (Edinburgh), 2016-06, Vol.27, p.99-104

2016

Volltextzugriff (PDF)

Modeling hot flushes and quality of life in breast cancer survivors

Climacteric : the journal of the International Menopause Society, 2011-02, Vol.14 (1), p.171-180

2011

Volltextzugriff (PDF)

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study

British journal of cancer, 2010-07, Vol.103 (3), p.291-296

2010

Volltextzugriff (PDF)

ES1-3: Treatment of Metastatic Breast Cancer – Breast Cancer as a Chronic Disease: Triple Negative Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.ES1-3-ES1-3

Stearns, V

2011

Volltextzugriff (PDF)

Estrogen Receptor Genotypes, Menopausal Status, and the Effects of Tamoxifen on Lipid Levels: Revised and Updated Results

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.626-629

2010

Volltextzugriff (PDF)

Phase I/II Trial of Partial Breast Irradiation (PBI) With Various Concurrent Chemotherapy Regimens: Assessment of Skin Toxicity, Cosmetic Outcomes, and Disease Recurrence

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S219-S220

2012

Volltextzugriff (PDF)

1 – 25 von 428

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(350)
Mit Volltextzugriff
(370)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(194)
Publisher or Other Site
(184)
Ingenta
(129)
Journals@Ovid Full Text
(122)
MEDLINE
(108)
ScienceDirect
(66)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(42)
American Physical Society
(39)
PROLA
(39)
Wiley Online Library
(36)
IngentaConnect Journals
(29)
IEEE/IET Electronic Library
(26)
Springer Online Journals
(16)
Oxford journals
(15)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(12)
Wiley Online Library
(12)
Springer Book Series
(12)
JSTOR
(11)
Oxford Journals 2020 Medicine
(10)
AIP Journals
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)

Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006

CYP2D6 Genotype, Antidepressant Use, and Tamoxifen Metabolism During Adjuvant Breast Cancer Treatment

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

When Is a Tumor Marker Ready for Prime Time? A Case Study of c-erbB-2 as a Predictive Factor in Breast Cancer

Abstract ED01-01: Optimizing endocrine therapy in premenopausal women

Abstract CS1-2: Searching for the optimal duration of adjuvant endocrine therapy in breast cancer

Plasma Letrozole Concentrations in Postmenopausal Women With Breast Cancer Are Associated With CYP2A6 Genetic Variants, Body Mass Index, and Age

Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

Predictors of recovery of ovarian function during aromatase inhibitor therapy

Increased African-American Enrollment in Breast Cancer Clinical Trials: A Single-Institution Experience

A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors

Two Phase 1/2 Trials of Partial Breast Irradiation (PBI) With Concurrent Chemotherapy Regimens: Late Toxicity, Cosmetic Outcome, and Disease Recurrence

Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects

New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17

Modeling hot flushes and quality of life in breast cancer survivors

Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study

ES1-3: Treatment of Metastatic Breast Cancer – Breast Cancer as a Chronic Disease: Triple Negative Breast Cancer

Estrogen Receptor Genotypes, Menopausal Status, and the Effects of Tamoxifen on Lipid Levels: Revised and Updated Results

Phase I/II Trial of Partial Breast Irradiation (PBI) With Various Concurrent Chemotherapy Regimens: Assessment of Skin Toxicity, Cosmetic Outcomes, and Disease Recurrence

Suchergebnisse filtern